Provided by Tiger Trade Technology Pte. Ltd.

Atrium Therapeutics

13.23
+0.13000.99%
Post-market: 13.230.00000.00%19:16 EDT
Volume:410.78K
Turnover:5.39M
Market Cap:205.26M
PE:-4.15
High:13.28
Open:13.00
Low:12.90
Close:13.10
52wk High:16.77
52wk Low:11.95
Shares:15.52M
Float Shares:11.14M
Volume Ratio:0.63
T/O Rate:3.69%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.1910
EPS(LYR):-3.1905
ROE:-43.98%
ROA:-399.25%
PB:-3.27
PE(LYR):-4.15

Loading ...

Assessing Avidity Biosciences (RNA) Valuation After Its Strong Multi‑Year Share Price Rally

Simply Wall St.
·
Dec 08, 2025

ProQR to Participate in 8th Annual Evercore Healthcare Conference

GlobeNewswire
·
Dec 01, 2025

Will FDA Accelerated Pathway for Delpacibart Zotadirsen Reshape Avidity Biosciences' (RNA) Rare Disease Trajectory?

Simply Wall St.
·
Nov 27, 2025

BUZZ-Sarepta rises after U.S. FDA clears study of muscle-wasting disease drug

Reuters
·
Nov 25, 2025

Silexion Therapeutics completes toxicology studies for SIL204

TIPRANKS
·
Nov 25, 2025

Silexion Therapeutics Successfully Completes Toxicology Studies for SIL204, Next-Generation RNA Silencing Therapy, Ahead of Phase 2/3 Clinical Trial in Pancreatic Cancer

GlobeNewswire
·
Nov 25, 2025

Avidity Biosciences Inc. Announces Date for Special Stockholders Meeting

Reuters
·
Nov 25, 2025

Sarepta provides update on SRP-1003 study

TIPRANKS
·
Nov 24, 2025

CSPC PHARMA (01093): Dual-Chain Small Interfering RNA Drug (SYH2061 Injection) Receives US Clinical Trial Approval

Stock News
·
Nov 24, 2025

HK Stock Movement | MIRXES-B (02629) Rises Nearly 8% in Early Trading, Partners with Walvax to Expand ASEAN Market and Build RNA Precision Medicine Innovation System

Stock News
·
Nov 24, 2025

HK Stock Movement | MIRXES-B (02629) Rises Over 5% in Afternoon Trading on Partnership with Walvax to Build RNA-Centric Precision Medicine Platform

Stock News
·
Nov 21, 2025

Biotech Reawakens: Policy Clarity, Breakthrough Data and a Surge in M&A

LiveWire
·
Nov 21, 2025

These 15 stocks are still showing momentum - and a market-beating edge

Dow Jones
·
Nov 21, 2025

Novartis Projects Faster Growth Through 2030 After Raising Drug Forecasts

Benzinga
·
Nov 21, 2025

Novartis Expects Key Drugs, Recent Deals to Buoy Sales Into 2030s -- Update

Dow Jones
·
Nov 20, 2025

Novartis sees sales boost from key cancer drugs

Reuters
·
Nov 20, 2025

Novartis Forecasts 2025-2030 Sales CAGR Of +5-6% CC

Reuters
·
Nov 20, 2025

BRIEF-Avidity Biosciences Announces U.S. Managed Access Program (Map) For Investigational Therapy Del-Zota In Dmd44

Reuters
·
Nov 19, 2025

Avidity Biosciences Inc - Plans Bla Submission for Del-Zota in 2026

THOMSON REUTERS
·
Nov 19, 2025

BAIJIN LIFE SCI (01466) Subsidiary Plans to Invest in YouHuan Bio to Build a Globally Leading circRNA Technology R&D Platform

Stock News
·
Nov 19, 2025